|
ATNM Actinium Pharmaceuticals Inc 1388320 |
| Balance Sheet |
|
Current Assets
|
79,520,000 |
|
Assets
|
82,114,000 |
|
Current Liabilities
|
7,755,000 |
|
Liabilities
|
43,906,000 |
|
Equity
|
38,208,000 |
|
Shares Out
|
31,154,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-27,321,000 |
|
Investing Cash Flow
|
-11,000 |
| Market Analysis |
Market Cap
|
57,479,813 |
|
Price
|
1.43 |
|
BVPS
|
1.23 |
|
PB
|
0.98 |
|
EPS
|
-1.52 |
|
PS
|
3.13 |
|
FCF
|
-27,332,000 |
|
| Earnings |
|
| Oct |
Nov |
Dec |
| 10/31 |
|
11/14 |
-0.37 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ATNM documents filed with the SEC.
ATNM Filings
Clear
